Viewing StudyNCT02821754



Ignite Creation Date: 2024-05-06 @ 8:47 AM
Last Modification Date: 2024-10-26 @ 12:05 PM
Study NCT ID: NCT02821754
Status: COMPLETED
Last Update Posted: 2023-03-28
First Post: 2016-06-29

Brief Title: A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma HCC or Biliary Tract Carcinomas BTC
Sponsor: National Cancer Institute NCI
Organization: National Institutes of Health Clinical Center CC

Conditions & Keywords Data

Conditions:
Name
Bile Duct Cancer
Biliary Tract Neoplasms
Liver Cancer
Hepatocellular Carcinoma
Cholangiocarcinoma
Keywords:
Name View
Combination of Tremelimumab and Durvalumab View
PDL1-Mediated Adaptive Resistance View
Monoclonal Antibody View
CTLA-4 View
Ablative Therapy View